In a nutshell This study examined risk factors of adverse pregnancy outcomes and the mother’s future diabetes risk in gestational diabetes mellitus (GDM) pregnancies. Researchers reported that fasting blood glucose levels at GDM diagnosis were a significant predictor of infant birth weight and maternal diabetes risk. Some background When a...
Read More
In a nutshell This study examined the impact of diabetes duration on bone fracture risk. Researchers concluded that the presence of diabetes significantly increased the risk of bone fractures. Higher risks were observed for patients with longer durations of diabetes. Some background Diabetes is associated with an increased risk of bone fractures....
Read MoreIn a nutshell The authors aimed to formulate guidelines for the use of continuous glucose monitoring (CGM) and continuous subcutaneous insulin infusion (CSII) in patients with diabetes. Some background CGM is a technology that involves wearing a small device that tracks blood sugar levels throughout the day and night. This device will...
Read More
In a nutshell The main objective of this study was to determine the impact of nocturnal hypoglycemia on sleep patterns in patients with type 2 diabetes. The authors concluded that nocturnal hypoglycemia caused a decrease in a patient's ability to wake up and respond to episodes of low blood sugar levels. Some background Nocturnal hypoglycemia...
Read MoreIn a nutshell The main objective of this study was to determine the effectiveness and safety of dulaglutide (Trulicity) compared to liraglutide (Victoza) in patients with type 2 diabetes. The authors concluded that once-weekly treatment with dulaglutide was an effective and safe treatment in patients with type 2...
Read More
In a nutshell The main objective of this analysis was to determine the benefit of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compared to insulin treatment in patients with type 2 diabetes who were receiving treatment with oral glucose-lowering medications (OGLM – used to produce insulin in patients who cannot produce enough by...
Read MoreIn a nutshell The main objectives of this study was to determine the long term effect and safety of lixisenatide (Lyxumia) as an add-on therapy in type 2 diabetes. The authors concluded that lixisenatide provided long-term blood sugar control, reduced weight and was a safe method of treatment in patients with type 2 diabetes. Some background...
Read More
Holly Clegg shares another of her delicious recipes for the holidays. Here’s one from Eating well to Fight Arthritis (inflammation recipe) called Stuffed Bell Pepper Bake To Fight Inflammation. Anti-Inflammatory Foods What’s the big deal about anti-inflammatory foods? Certain foods can actually help ease arthritis symptoms. Chronic, or...
Read More
In a nutshell The authors aimed to determine the benefit of islet transplantation in controlling glucose levels and counterregulation in patients with type 1 diabetes. The authors concluded that islet transplantation can lead to long-term improvements in glucose levels and low blood sugar symptom recognition that contributes to stable blood sugar...
Read More
In a nutshell The authors aimed to determine the safety and efficacy of saxagliptin (Onglyza) as an add-on treatment in patients with type 2 diabetes already receiving treatment with dapagliflozin (Farxiga) and metformin (Glucophage). The authors concluded that using saxagliptin as an add-on treatment for 52 weeks resulted in improvements in blood...
Read MoreIn a nutshell The main objective of this trial is to determine whether repeat bacillus Calmette-Guerin (BCG) injections can benefit the immune system of patients with type 1 diabetes. The main outcome to be measured is change in HbA1c levels (average blood glucose over 3 months). This trial is being conducted in Boston, Massachusetts (US). The details...
Read MoreIn a nutshell The authors aimed to determine the effect of liraglutide (Victoza) on liver fat content in patients with uncontrolled type 2 diabetes. The authors concluded that six months treatment with liraglutide significantly reduced liver fat content in patients with uncontrolled type 2 diabetes by reducing body weight. Some...
Read More
